Provided by Tiger Trade Technology Pte. Ltd.

VanEck Pharmaceutical ETF

109.44
-0.1600-0.15%
Post-market: 109.440.00000.00%19:30 EDT
Volume:128.97K
Turnover:14.12M
Market Cap:1.01B
PE:88.68
High:110.48
Open:110.00
Low:109.17
Close:109.60
52wk High:118.00
52wk Low:85.91
Shares:9.19M
Float Shares:9.19M
Volume Ratio:0.66
T/O Rate:1.40%
Dividend:2.17
Dividend Rate:1.98%
EPS(TTM):1.23
EPS(LYR):0.7765
ROE:--
ROA:--
PB:--
PE(LYR):140.94

Loading ...

AbbVie to Present at Morgan Stanley Global Healthcare Conference Fireside Chat

Reuters
·
Sep 03

Superluminal Medicines: Financing Led by Bvf Partners; Alongside Existing Investors Nvidia, Eli Lilly & Co, Cooley, and Gaingels, Among Others

THOMSON REUTERS
·
Sep 03

Rothschild & Co Redburn Adjusts PT on Eli Lilly and Co. to $930 From $915, Keeps Neutral Rating

MT Newswires Live
·
Sep 03

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Sep 03

Option traders moderately bearish in Eli Lilly with shareslittle changed

TIPRANKS
·
Sep 03

H.C. Wainwright views Novartis, Alteogen pact as negative for Halozyme

TIPRANKS
·
Sep 03

Novartis AG Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

MT Newswires Live
·
Sep 02

Novo Nordisk A/S Stock (NVO) Moved Up by 3.17% on Sep 2: What Signal Does It Send?

TradingKey
·
Sep 02

Pharma Giant Novo Nordisk’s Stock (NVO) Jumps Even as Deutsche Bank Repeats Sell Call

TIPRANKS
·
Sep 02

Aspen Bets on Manufacturing Rebound, Obesity Drug Push for Growth

Reuters
·
Sep 02

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
Sep 02

Allergan Aesthetics Unveils Layered Beauty Report on Global Shift Toward Personalized Aesthetic Care

Reuters
·
Sep 02

Novartis, Alteogen Sign Drug-Technology Deal Worth Up to $3.2 Billion

MT Newswires Live
·
Sep 02

Alteogen enters option, license agreement with Novartis

TIPRANKS
·
Sep 02

Merck CFO Litchfield, R&D Chief Li to Speak at Wells Fargo Healthcare Conference

Reuters
·
Sep 02

Novartis Trial Suspensions to Have Limited Financial Impact

Dow Jones
·
Sep 02

Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug

Simply Wall St.
·
Sep 02

AbbVie Inc. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 02